Instrument Inactif

Communiqués SciBase Holding AB (publ)

Actions

Equipement et technologie médicale avancés

Cours en clôture Nasdaq Stockholm Autres places de cotation
- ^SEK	-

02/03	SciBase obtient l'approbation de la FDA américaine pour étendre l'usage de son dispositif de détection du cancer de la peau	MT
07/11	SciBase et Castle Biosciences élargissent leur accord de licence et obtiennent un prêt de 20 millions de couronnes suédoises	MT

Communiqués

28/05	SciBase announces that the board of directors has resolved on the record date for the reverse share split	AQ
28/05	Nevisense detects skin barrier damage by chemicals used in household cleaning products in a new ex-vivo study	AQ
19/05	Bulletin from the annual general meeting in SciBase Holding AB (publ)	AQ
18/05	Scibase : Presentation proposed board of directors	PU
18/05	SciBase Announces New Research Highlighting Nevisense's Potential in Detecting Age-Related Skin Barrier Changes	AQ
13/05	SciBase (Q1 Review): Progress across key growth drivers	AQ
07/05	Interim report	AQ
27/04	Scibase : Annual report 2025 Press Release	PU
27/04	Scibase : Annual report 2025 Report	PU
27/04	SciBase publishes the Annual report for 2025	AQ
14/04	Notice to attend the annual general meeting in Scibase Holding AB (publ)	AQ
07/04	SciBase : reaches milestone with over 400,000 tests sold with Nevisense	PU
16/03	SciBase (Q4 Review): Strong growth, key catalysts ahead	AQ
13/03	Interim report	AQ
10/03	New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment	AQ
05/03	New Publication: US clinicians' real-world Nevisense experience improves melanoma detection	AQ
02/03	SciBase receives approval by FDA for extended labelling in the US	AQ
19/02	SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma	AQ
17/02	A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns	AQ
06/02	Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue	AQ
27/01	SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2	AQ
26/01	Change of date for publication of the year-end report for the financial year 2025	AQ
22/01	Increased commitment in SciBase rights issue	AQ
12/01	SciBase announces outcome of the offer to repurchase outstanding warrants of series to 2	AQ
09/01	SciBase publishes information document regarding rights issue	AQ